FREE Shippingto US, AU, UK and EU on all orders over $149
/

Chondroxide 5% 30g ointment tube

$24.40

d10ef64d6363

Description

The instruction for medical use

of Hondroksid Torgovoye medicine a name

Hondroksid

Mezhdunarodnoye the unlicensed name

Is not present

the Dosage form

Ointment for external use of 5%

Structure

of 1 g of ointment contains

active agent – sodium sulfate chondroitin (in terms of 100% substance) 0.05 g

excipients: a dimethyl sulfoxide (Dimexidum), lanolin (lanolin anhydrous, wax woolen), the vaseline, monoglycerides distilled the water purified.

The description

Ointment of light yellow color with a dimethyl sulfoxide smell.

Pharmacotherapeutic group

Other drugs for topical treatment of diseases of the musculoskeletal system.

The code of automatic telephone exchange

the Pharmacological

Pharmacokinetics properties

Hondroksid ointment is well soaked up by M02AX. According to the data obtained in pilot studies on mice with use of radio marked 3H-chondroitin of sulfate, the rate of absorbability of chondroitin of sulfate is 14%. The dimethyl sulfoxide promotes the best penetration of chondroitin of sulfate through cellular membranes deep into of fabrics. Chondroitin sulfate, after putting drug Hondroksid ointment on skin, quickly and selectively comes to a joint with achievement of the maximum concentration in 30 minutes and the subsequent two-phase removal of drug from cartilaginous tissue. End of a fast phase of removal happens in 1 hour after use. Time of deduction of drug in a joint is 5 hours.

The pharmacodynamics

the Main active ingredient of drug is chondroitin sulfate – the high-molecular mucopolysaccharide which is slowing down a resorption of a bone tissue and reducing calcium loss. Chondroitin sulfate improves phosphorus-calcium exchange in cartilaginous tissue, accelerates processes of recovery of a bone tissue, slows down processes of a degeneration (destruction) of cartilaginous tissue. Interferes with collapse of connective tissue, inhibits the enzymes causing damage to cartilaginous tissue, stimulates synthesis of glucosaminoglycans, promotes regeneration (restoration) of an articulate bag and the cartilaginous surfaces of joints, increases products of intra articulate liquid. Slows down progressing of an osteoarthrosis and osteochondrosis, normalizes a metabolism in hyaline fabric, has anesthetic and anti-inflammatory effect. It leads to increase in mobility of the affected joints.

The dimethyl sulfoxide which is a part of ointment has anti-inflammatory, analgetic and fibrinolytic effect, the best penetration is promoted by sulfate chondroitin through cellular membranes.

Indications

– degenerative dystrophic diseases of joints and a backbone (treatment and prevention of an osteoarthrosis, osteoarthrosis of a temporal and mandibular joint, a spondylarthrosis, osteochondrosis, osteoporosis, a heyroartropatiya)

the Route of administration and doses

Outwardly. Ointment Hondroksid is applied by 2-3 times a day to skin over the center of defeat and rub within 2-3 minutes before full absorption. A course of treatment – from 2-3 weeks to 2-3 months. If necessary the course of treatment is repeated.

Side effects

– allergic reactions.

Contraindications

– hypersensitivity to drug components

– damage of integuments in the field of putting drug

Medicinal interactions

Cases of interaction or incompatibility with other medicines are not described.

Special instructions

It is necessary to avoid hit of drug on mucous membranes and open wounds.

Children’s age

the Efficiency and safety of use of Hondroksid at children’s age are not established.

Pregnancy and a lactation

Use during pregnancy and a lactation is possible when the expected advantage of use of drug for mother exceeds potential risk

for a fruit or the child.

The feature of influence of medicine on ability to drive the car or potentially dangerous mechanisms

does not influence ability to drive the car or potentially dangerous mechanisms.

Overdose

About drug Hondroksid&Ograve overdose cases, ointment it was not reported.

A form of release and packing

On 30 g in tubas aluminum.

Each tuba together with the instruction for medical use in the state and Russian languages is placed in a pack from cardboard.

To Store storage conditions at

a temperature not higher than 25 S. Hranit out of children’s reach!

A period of storage

3 years

not to use drug after an expiration date.

Prescription status

Without prescription

JSC Nizhpharm Producer,

Russian Federation 603950, Nizhny Novgorod, GSP-459, Salganskaya St., 7

ph.: (831) 278-80-88

fax: (831) 430-72-28

a web the website: http://www.nizhpharm.ru

the Name and the country of the owner of the registration certificate

of JSC Nizhpharm, the Russian Federation

the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products (goods)

Representative office of JSC Nizhpharm

050043, Republic of Kazakhstan, Almaty, mdt. Khan-Taniri, 55b

ph.: (727) 271-99-68

fax: (727) 255-33-78

email: almaty@stada.kz

Additional information

Ingredient

Reviews

There are no reviews yet.

Be the first to review “Chondroxide 5% 30g ointment tube”

Your email address will not be published.